ライフサイエンスコーパス: decaffeinated

1 nce = 29.6 ml) of coffee per week (including decaffeinated) at the last menstrual period; and were en

2 demiologic studies link caffeinated (but not decaffeinated) beverage intake with significant decrease

3 tea, decaffeinated green tea plus caffeine, decaffeinated black tea plus caffeine, or caffeine alone

4 High intake of caffeinated and decaffeinated coffee (2 or more cups/day) was associated

5 caffeinated (P value for trend < 0.001) and decaffeinated coffee (P value for trend = 0.022).

6 udy, we associated intake of caffeinated and decaffeinated coffee after diagnosis of CRC with lower r

7 Similar findings were observed for decaffeinated coffee and coffee additives.

8 Similar associations were found for decaffeinated coffee and for coffee with additives.Drink

9 arts and that the neuroprotective effects of decaffeinated coffee and nicotine-free tobacco are also

10 We further report that decaffeinated coffee and nicotine-free tobacco are as ne

11 e report that the neuroprotective effects of decaffeinated coffee and nicotine-free tobacco require t

12 ation between consumption of caffeinated and decaffeinated coffee and risk of mortality remains incon

13 Further investigations of decaffeinated coffee and tea intake as arthritis risk fa

14 Intakes of decaffeinated coffee and tea were not associated with ri

15 association between consumption of coffee or decaffeinated coffee and the risk of rheumatoid arthriti

16 concluded that ingestion of caffeinated and decaffeinated coffee can reduce the risk of diabetes.

17 variate model using only baseline reports of decaffeinated coffee consumption (RR 1.0, 95% CI 0.6-1.7

18 s of RA onset with the highest categories of decaffeinated coffee consumption (RR 3.10, 95% CI 1.75-5

19 d not find a significant association between decaffeinated coffee consumption of >/=4 cups/day (compa

20 Decaffeinated coffee consumption was associated with a s

21 Higher decaffeinated coffee consumption was associated with low

22 Decaffeinated coffee consumption was not associated with

23 nsumption of >/=4 cups/day (compared with no decaffeinated coffee consumption) and subsequent risk of

24 ine intake from all sources combined or with decaffeinated coffee consumption.

25 One short-term study found that ground decaffeinated coffee did not increase blood pressure.

26 Decaffeinated coffee did not increase risk for any perin

27 were seen for substitution of caffeinated or decaffeinated coffee for low-calorie soda.

28 ted coffee high in chlorogenic acid (C-HCA), decaffeinated coffee high in chlorogenic acid, or decaff

29 o examine the consumption of caffeinated and decaffeinated coffee in relation to cardiovascular disea

30 < 0.0001) and 4% for caffeinated and 7% for decaffeinated coffee in the HPFS (P < 0.01)].

31 [RR per serving: 8% for both caffeinated and decaffeinated coffee in the NHS (P < 0.0001) and 4% for

32 Similar inverse associations were found with decaffeinated coffee intake and abnormal levels of ALT (

33 and cognitive function among men or between decaffeinated coffee intake and cognitive function in ei

34 Decaffeinated coffee intake is independently and positiv

35 lly, few studies have considered exclusively decaffeinated coffee intake or use of coffee additives.

36 an systolic or diastolic blood pressure, but decaffeinated coffee intake was associated with a small

37 Decaffeinated coffee intake was not associated with mean

38 An inverse association for >2 cups/day of decaffeinated coffee intake was suggested (relative risk

39 examined the association of caffeinated and decaffeinated coffee intake with cognitive function in a

40 However, it is unclear whether decaffeinated coffee is also associated with liver enzym

41 In contrast, neither decaffeinated coffee nor tea was associated with SHBG or

42 products (caffeinated soda, caffeinated tea, decaffeinated coffee or chocolate) and risk of EG/EGS (P

43 in a double-blind design, 40 mL of either a decaffeinated coffee preparation plus 3 mg caffeine/kg (

44 However, the ability of decaffeinated coffee to achieve these effects is based o

45 The odds ratio for drinking > 1 cup/day of decaffeinated coffee versus nondrinkers was 1.25 (95% CI

46 nversely, the consumption of caffeinated and decaffeinated coffee was associated with a lower risk of

47 Decaffeinated coffee was associated with a trend toward

48 ion of total coffee, caffeinated coffee, and decaffeinated coffee was associated with lower risk of t

49 In contrast, decaffeinated coffee was not associated with a decreased

50 affeine from sources other than coffee or of decaffeinated coffee was not associated with reduced liv

51 In contrast, decaffeinated coffee was not associated with risk.

52 o use, subjects drinking > or =4 cups/day of decaffeinated coffee were at increased risk of RA (RR 2.

53 Consumption of total, caffeinated, and decaffeinated coffee were nonlinearly associated with mo

54 Nonherbal tea and decaffeinated coffee were not associated with patient ou

55 There were no significant associations of decaffeinated coffee with liver markers.

56 feinated coffee high in chlorogenic acid, or decaffeinated coffee with regular amounts of chlorogenic

57 ns of consumption of total, caffeinated, and decaffeinated coffee with risk of subsequent total and c

58 coffee, 10% (95% confidence interval 4-15%); decaffeinated coffee, 10% (3-16%); tea, 14% (5-22%); bee

59 r caffeinated coffee, 9% (CI, 2% to 15%) for decaffeinated coffee, 8% (CI, 1% to 15%) for tea, and 59

60 intake (mg/d) or cups of caffeinated coffee, decaffeinated coffee, and caffeinated tea.

61 se findings suggest that caffeinated coffee, decaffeinated coffee, and caffeine are not risk factors

62 The mean intakes of caffeinated coffee, decaffeinated coffee, and caffeine were 2-3 cups/d, 1 cu

63 Intakes of caffeinated coffee, decaffeinated coffee, and caffeine were not associated w

64 s of baseline intakes of caffeinated coffee, decaffeinated coffee, and caffeine with measured systoli

65 Total caffeine, regular coffee, decaffeinated coffee, and regular tea intake were not as

66 examined associations of caffeinated coffee, decaffeinated coffee, and tea intake with fatal oral/pha

67 gated the association of caffeinated coffee, decaffeinated coffee, and tea with myocardial infarction

68 ongitudinal relations of caffeinated coffee, decaffeinated coffee, and total caffeine intakes with me

69 e evidence of an association between coffee, decaffeinated coffee, or tea consumption and the risk of

70 We assessed the consumption of coffee, decaffeinated coffee, tea, and total caffeine in partici

71 For decaffeinated coffee, the multivariate relative risks co

72 For decaffeinated coffee, the multivariate RRs according to

73 Decaffeinated coffee, therefore, may be the type of coff

74 We studied whether coffee, decaffeinated coffee, total coffee, tea, or overall caff

75 Trends were similar between caffeinated and decaffeinated coffee.

76 l cancers for people who drank predominantly decaffeinated coffee.

77 0.001), and tea (p for trend = 0.02) but not decaffeinated coffee.

78 ving of sugar-sweetened soda/d, 1 serving of decaffeinated coffee/d was associated with a 10% (95% CI

79 sumption categories (0, 1-237, and >/=237 mL decaffeinated coffee/d) were 1.00, 1.02, and 0.77 (95% C

80 nated coffee/mo and 75% consumed > or =1 cup decaffeinated coffee/mo; the corresponding intakes for w

81 seen for diet cola and, although weaker, for decaffeinated cola.

82 different characteristics (soluble, ground, decaffeinated, etc) were evaluated for antioxidant capac

83 e relation between long-term caffeinated and decaffeinated filtered coffee consumption and markers of

84 esults indicate that neither caffeinated nor decaffeinated filtered coffee has a detrimental effect o

85 Oral administration of decaffeinated green or black tea resulted in substantial

86 caffeinated beverages (green tea, black tea, decaffeinated green tea plus caffeine, decaffeinated bla

87 0.77; 95% CI: 0.63, 0.94; P-trend 0.009) and decaffeinated (HR: 0.70; 95% CI: 0.46, 1.06; P-trend: 0.

88 affeinated (HR: 0.94; 95% CI: 0.84, 1.05) or decaffeinated (HR: 1.05; 95% CI: 0.84, 1.31) coffee cons

89 ated coffee and tea intakes (caffeinated and decaffeinated) in relation to colon (proximal and distal

90 (FDIT), spray-dried instant tea (SDIT), and decaffeinated instant tea (DCIT)], were compared for the

91 tives.Drinking coffee, either caffeinated or decaffeinated, may lower the risk of CVD and IHD mortali

92 , administration of a high-dose level of the decaffeinated teas enhanced the tumorigenic effect of UV

93 Administration of the decaffeinated teas had little or no effect on these para

94 d carcinogenesis, and adding caffeine to the decaffeinated teas restored the inhibitory effects of th

95 nt to the amount in the regular teas) to the decaffeinated teas restored their inhibitory effects.